|
The Advisory Board Company
September 6, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating The Advisory Board Company ("Advisory Board” or the "Company") (NASDAQ: ABCO), a company that provides performance-improvement software and services to the healthcare and education industries. Investors who purchased shares of Advisory Board common stock may be affected.
|
|
SteadyMed Ltd.
September 1, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SteadyMed Ltd. (“SteadyMed” or the “Company”) (NASDAQ: STDY).
|
|
DryShips Inc.
September 1, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DryShips Inc. (“DryShips” or the “Company”) (NASDAQ: DRYS).
|
|
Envision Healthcare Corporation
August 22, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Envision Healthcare Corporation (“Envision Healthcare” or the “Company”) (NYSE: EVHC).
|
|
Sequans Communications S.A.
August 22, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Sequans Communications S.A. (“Sequans” or the “Company”) (NYSE: SQNS).
|
|
American Public Education
August 10, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of American Public Education, Inc. (“American Public Education” or the “Company”) (NASDAQ APEI). Investors who purchased shares of American Public Education securities may be affected.
|
|
GlobalSCAPE, Inc.
August 8, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GlobalSCAPE, Inc. (“GlobalSCAPE” or the “Company”) (NYSE MKT: GSB). Investors who purchased shares of GlobalSCAPE common stock may be affected.
|
|
Arconic, Inc.
July 27, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Arconic, Inc. (“Arconic” or the “Company”) (NYSE: ARNC). Investors who purchased shares of Arconic securities between November 4, 2013 and June 26, 2017 (the “Class Period”) may be affected.
|
|
Ocular Therapeutix, Inc.
July 19, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Ocular Therapeutix, Inc. (“Ocular Therapeutix” or the “Company”) (NASDAQ: OCUL).
|
|
Mazor Robotics Ltd.
June 20, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Mazor Robotics Ltd. (“Mazor” or the “Company”) (NASDAQ: MZOR).
|
|
Booz Allen Hamilton Holding Corporation
June 16, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Booz Allen Hamilton Holding Corporation (“Booz Allen” or the “Company”) (NYSE: BAH). Investors who purchased shares of Booz Allen securities may be affected.
|
|
Synchronoss Technologies, Inc.
June 14, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (NASDAQ: SNCR). Investors who purchased shares of Synchronoss securities may be affected.
|
|
Credit Acceptance Corporation
May 4, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Credit Acceptance Corporation ("Credit Acceptance” or the "Company") (NASDAQ: CACC), a subprime auto lender, for potential violations of the federal securities laws. Investors who purchased shares of Credit Acceptance common stock may be affected.
|
